Difference between revisions of "Forodesine (Fodosine)"
Jump to navigation
Jump to search
m |
m |
||
Line 8: | Line 8: | ||
==Also known as== | ==Also known as== | ||
− | Immucillin H | + | *'''Code name:''' BCX-1777 |
+ | *'''Generic name:''' Immucillin H | ||
+ | *'''Brand name:''' Fodosine, Mundesine | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
+ | [[Category:Oral medications]] | ||
[[Category:Chemotherapy]] | [[Category:Chemotherapy]] | ||
Revision as of 18:18, 28 November 2017
Mechanism of action
Purine nucleoside phosphorylase (PNP) inhibitor
Preliminary data
Cutaneous T-cell lymphoma
- Dummer R, Duvic M, Scarisbrick J, Olsen EA, Rozati S, Eggmann N, Goldinger SM, Hutchinson K, Geskin L, Illidge TM, Giuliano E, Elder J, Kim YH. Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Ann Oncol. 2014 Sep;25(9):1807-12. Epub 2014 Jun 19. link to original article PubMed
Also known as
- Code name: BCX-1777
- Generic name: Immucillin H
- Brand name: Fodosine, Mundesine